Literature DB >> 12869631

The mechanism of action of aniracetam at synaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors: indirect and direct effects on desensitization.

J Josh Lawrence1, Stephan Brenowitz, Laurence O Trussell.   

Abstract

The mechanism of action of aniracetam on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors was examined in outside-out patches and at glutamatergic synapses in neurons of the chick cochlear nucleus. A combination of rapid-flow analysis, using glutamate as an agonist, and kinetic modeling indicated that aniracetam slows both the rate of channel closing, and the microscopic rates of desensitization, even for partially liganded receptors. Little effect was observed on the rate of recovery from desensitization or on the response to the weakly desensitizing agonist kainate. Aniracetam's effects on receptor deactivation saturated at lower concentrations than its effects on desensitization, suggesting that cooperativity between homologous binding sites was required to regulate desensitization. Analysis of responses to paired pulses of agonist also indicated that AMPA receptors must desensitize partially even after agonist exposures too brief to permit rebinding. In the presence of aniracetam, evoked excitatory synaptic currents (EPSCs) and miniature EPSCs in low quantal-content conditions had decay times similar to the time course of receptor deactivation. Under these conditions, the time course of both transmitter release and clearance must be <1 to 2 ms. However, in high quantal-content conditions, the evoked EPSC in aniracetam decayed with a time course intermediate between deactivation and desensitization, suggesting that the time course of transmitter clearance is prolonged because of pooling of transmitter in the synaptic cleft. Moreover, by comparing the amounts of paired-pulse synaptic depression and patch desensitization prevented by aniracetam, we conclude that significant desensitization occurs in response to rebinding of transmitter to the AMPA receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12869631     DOI: 10.1124/mol.64.2.269

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  12 in total

1.  Mechanisms underlying signal filtering at a multisynapse contact.

Authors:  Timotheus Budisantoso; Ko Matsui; Naomi Kamasawa; Yugo Fukazawa; Ryuichi Shigemoto
Journal:  J Neurosci       Date:  2012-02-15       Impact factor: 6.167

2.  Targeting AMPA receptor gating processes with allosteric modulators and mutations.

Authors:  Nicholas A Mitchell; Mark W Fleck
Journal:  Biophys J       Date:  2007-01-05       Impact factor: 4.033

Review 3.  Therapeutic potential of positive AMPA receptor modulators in the treatment of neuropsychiatric disorders.

Authors:  Stefano Marenco; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  The Transmembrane Domain of Synaptobrevin Influences Neurotransmitter Flux through Synaptic Fusion Pores.

Authors:  Chung-Wei Chiang; Che-Wei Chang; Meyer B Jackson
Journal:  J Neurosci       Date:  2018-07-16       Impact factor: 6.167

5.  Lithium acts as a potentiator of AMPAR currents in hippocampal CA1 cells by selectively increasing channel open probability.

Authors:  Christine Gebhardt; Stuart G Cull-Candy
Journal:  J Physiol       Date:  2010-08-31       Impact factor: 5.182

6.  AMPA receptor positive allosteric modulators attenuate morphine tolerance and dependence.

Authors:  Xiaoyu Hu; Xuebi Tian; Xiao Guo; Ying He; Haijun Chen; Jia Zhou; Zaijie Jim Wang
Journal:  Neuropharmacology       Date:  2018-04-25       Impact factor: 5.250

7.  Relative roles of different mechanisms of depression at the mouse endbulb of Held.

Authors:  Hua Yang; Matthew A Xu-Friedman
Journal:  J Neurophysiol       Date:  2008-03-26       Impact factor: 2.714

8.  Aniracetam does not improve working memory in neurologically healthy pigeons.

Authors:  Hannah Phillips; Arlene McDowell; Birgitte S Mielby; Ian G Tucker; Michael Colombo
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

Review 9.  Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic.

Authors:  Noor Azuin Suliman; Che Norma Mat Taib; Mohamad Aris Mohd Moklas; Mohd Ilham Adenan; Mohamad Taufik Hidayat Baharuldin; Rusliza Basir
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-30       Impact factor: 2.629

10.  Physiological signature of a novel potentiator of AMPA receptor signalling.

Authors:  Blanka R Szulc; Stephen T Hilton; Arnaud J Ruiz
Journal:  Mol Cell Neurosci       Date:  2018-07-22       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.